IAM

Iambic Therapeutics, Inc. - Common Stock (IAM)

About Iambic Therapeutics, Inc. - Common Stock (IAM)

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.

Details

Daily high

$17.50

Daily low

$15.00

Price at open

$16.31

52 Week High

$25.00

52 Week Low

$14.10

Market cap

774.5M

Dividend yield

Volume

734,579

Avg. volume

1.8M

P/E ratio

Iambic Therapeutics, Inc. - Common Stock News